Inflammatory markers for arterial stiffness in cardiovascular diseases

I Mozos, C Malainer, J Horbańczuk, C Gug… - Frontiers in …, 2017 - frontiersin.org
Arterial stiffness predicts an increased risk of cardiovascular events. Inflammation plays a
major role in large arteries stiffening, related to atherosclerosis, arteriosclerosis, endothelial …

Overview of epidemiology and contribution of obesity to cardiovascular disease

M Bastien, P Poirier, I Lemieux, JP Després - Progress in cardiovascular …, 2014 - Elsevier
The prevalence of obesity has increased worldwide and is a source of concern since the
negative consequences of obesity start as early as in childhood. The most commonly used …

Sarcopenic obesity: definition, cause and consequences

S Stenholm, TB Harris, T Rantanen… - Current Opinion in …, 2008 - journals.lww.com
Sarcopenic obesity: definition, cause and consequences : Current Opinion in Clinical Nutrition &
Metabolic Care Sarcopenic obesity: definition, cause and consequences : Current Opinion in …

Shift work and the risk for metabolic syndrome among healthcare workers: A systematic review and meta‐analysis

P Sooriyaarachchi, R Jayawardena, T Pavey… - Obesity …, 2022 - Wiley Online Library
Shift work, defined as work occurring outside typical daytime working hours, is associated
with an increased risk for metabolic syndrome (MetS) due to several biological and …

Interplay of skeletal muscle and adipose tissue: sarcopenic obesity

MJ Park, KM Choi - Metabolism, 2023 - Elsevier
Sarcopenic obesity is becoming a global health concern, owing to the rising older
population, causing cardiometabolic morbidity and mortality. Loss of muscle exceeding …

[HTML][HTML] Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome

MJ Dekker, Q Su, C Baker… - American Journal of …, 2010 - journals.physiology.org
As dietary exposure to fructose has increased over the past 40 years, there is growing
concern that high fructose consumption in humans may be in part responsible for the rising …

Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism

WL Holland, SA Summers - Endocrine reviews, 2008 - academic.oup.com
Obesity and dyslipidemia are risk factors for metabolic disorders including diabetes and
cardiovascular disease. Sphingolipids such as ceramide and glucosylceramides, while …

An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome

R Kumari, S Kumar, R Kant - … & Metabolic Syndrome: Clinical Research & …, 2019 - Elsevier
Background Metabolic syndrome is a collection of physiological and biochemical
abnormalities about 20–25% of adult population in developing countries is suffering from …

The Physiology of Obese‐Hyperglycemic Mice [ob/ob Mice]

P Lindström - The scientific world journal, 2007 - Wiley Online Library
This review summarizes key aspects of what has been learned about the physiology of
leptin deficiency as it can be observed in obese‐hyperglycemic ob/ob mice. These mice lack …

Targeting fatty acid metabolism to improve glucose metabolism

R Stinkens, GH Goossens, JWE Jocken… - Obesity …, 2015 - Wiley Online Library
Disturbances in fatty acid metabolism in adipose tissue, liver, skeletal muscle, gut and
pancreas play an important role in the development of insulin resistance, impaired glucose …